Canadian generic maker enters Korea with JV

Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint v...

January 3, 2013 | Thursday | News
Orexigen, Takeda file lawsuit against Actavis for patent infringement

Singapore: Orexigen Therapeutics and Takeda Pharmaceuticals have filed a lawsuit in US against Actavis for filing an abb...

June 8, 2015 | Monday | Regulatory
FDA warns Tianjin Zhongan for cGMP lapses

Singapore: The US Food and Drug Administration (FDA) has slapped a warning letter to China based Tianjin Zhongan Pharma...

June 26, 2014 | Thursday | Regulatory
Beximco pharma receives TFDA approval

Singapore: Beximco pharmaceuticals, a Bangladeshi pharma giant announced that it had received Good Manufacturing Practic...

July 4, 2014 | Friday | News
Teva to acquire migraine drug firm at $825 mn

Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...

June 4, 2014 | Wednesday | News
Mayne Pharma appoints a new vice president

Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business developmen...

June 18, 2014 | Wednesday | News
GSK seeks FIPB nod to hike stake in India

Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake ...

January 6, 2014 | Monday | News
Pharma FDI cap, right move for India

India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brown...

July 31, 2012 | Tuesday | Opinion
GSK CEO: London HQ 'knew nothing' of the fraud

Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest d...

July 25, 2013 | Thursday | News
FDA nod for Lupin's angina generic Ranolazine

Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg...

August 5, 2013 | Monday | News
Eli Lilly files $500 mn suit against Canada govt

Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the co...

September 16, 2013 | Monday | News
DRL launches Alchemia thrombosis generic in India

Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...

April 4, 2013 | Thursday | News
Abbott Laboratories unveils strategy for India

Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push ...

July 17, 2013 | Wednesday | News
Pfizer to acquire Innopharma at $360 mn

Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, in...

July 18, 2014 | Friday | News
Mylan launches operations in India with 18 ARV products

Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the...

August 9, 2012 | Thursday | News
Mundipharma appoints John Lee as GM for SEA

Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, t...

November 6, 2013 | Wednesday | Influencers
Dr Reddy's launches Eszopiclone tablets in US

Singapore: Dr Reddy's Laboratories has launched sedative drug, Eszopiclone tablets (C-IV) 1 mg, 2 mg and 3 mg, a therape...

April 16, 2014 | Wednesday | News
Bioscience firms queue up for Japan market

Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...

June 1, 2012 | Friday | Analysis